Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of active polypeptides in preparing anti-coronavirus medicaments and medical foods

An active polypeptide, coronavirus technology, applied in the field of biomedicine, can solve problems such as adverse reactions and antibody failure, and achieve the effects of low cost and convenient manufacturing

Inactive Publication Date: 2020-06-30
HUAZHONG UNIV OF SCI & TECH
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The vaccine is still in the process of research and development. Although the success of the vaccine research and development is relatively high, the vaccine is a gentle and mild pathogen designed for the structure of the virus. Adverse reactions of varying degrees
Moreover, the structure of this kind of cunning virus is constantly changing, and the antibodies produced by existing vaccines in the human body often fail, so it is necessary to continuously develop new vaccines to passively adapt to virus infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of active polypeptides in preparing anti-coronavirus medicaments and medical foods
  • Application of active polypeptides in preparing anti-coronavirus medicaments and medical foods
  • Application of active polypeptides in preparing anti-coronavirus medicaments and medical foods

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A kind of method of active peptide preparation is as follows:

[0026] 1. Put the seeds of legumes (such as soybeans, peas, etc.) in boiling water for 5 to 10 minutes, and then quickly cool them down to room temperature.

[0027] 2. Inoculate fermentation strains such as Bacillus subtilis according to a weight ratio of 1:1000, stir appropriately and place in a humid high-temperature (above 25°C) straw environment to ferment for 10-15 days to obtain fermentation materials (such as figure 1 as shown, figure 1 For soybean fermented material).

[0028] 3. Add an appropriate amount of water to the fermented material, pour it into a wall breaker, and then filter it with a 100-mesh sieve. At this time, the filtrate contains a variety of proteins and peptides.

[0029] 4. The filtrate is subjected to high-power ultrasonic crushing, and the protein and macromolecular peptides in the filtrate are broken into small molecular peptides.

[0030] 5. Filter the filtrate after ultra...

Embodiment 2

[0033] The 8 groups of 27 kinds of polypeptides obtained in Example 1 can all change the conformation of ACE2, so that ACE2 cannot bind to the virus. As for the docking of these small molecule peptides with ACE2 receptor molecules, the details are as follows:

[0034] ACE2 molecules are usually located on the luminal surface of epithelial cells, and when coronaviruses infect through the luminal surface of cells with ACE2, the infection efficiency is very high. Once the small molecule biologically active peptide binds to ACE2 through non-covalent bonds (hydrogen bonds, van der Waals attraction, hydrophobic or hydrophilic binding, and electrostatic attraction, etc.), the microenvironment of the cell surface changes, and the spatial conformation of ACE2 is affected by the small peptide. If changes occur, it will be difficult for coronaviruses such as SARS to interact with the extracellular domain of the ACE2 molecule and fail to mediate the entry of the virus into cells. Such as...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of active polypeptides in preparing anti-coronavirus medicaments and medical foods. The amino acid sequence of each active polypeptide is shown as any one of sequences SEQ ID:1-SEQ ID:27. The invention provides 27 kinds of active polypeptides with specific amino acid sequences, and the active polypeptides can be combined with receptors ACE2 of coronavirus oncells and inhibit the biological function of the ACE2, so that the ACE2 cannot be combined with coronavirus particles, and thus lung nociceptive diseases caused by the coronavirus can be prevented and / or treated. The group of food-derived bioactive peptides can be used for preparing medicaments for preventing or / and treating pulmonary inflammatory diseases caused by coronaviruses. The corresponding medicaments can be obtained, and are particularly suitable for treating pulmonary inflammatory diseases caused by a plurality of coronaviruses such as Sars-Cov, Mers-Cov and Sars-Cov2.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and more specifically relates to the application of an active polypeptide in the preparation of anti-coronavirus drugs and medical food. Background technique [0002] Angiotensin-Converting Enzyme 2, also known as Kininase 2 in the human body, (abbreviation: ACE 2, Chinese: Angiotensin-Converting Enzyme 2, also known as Kininase 2) is a variety of virus co-receptor proteins that cause human lung damage. These viruses, such as Sars-Cov, Mers-Cov and Sars-Cov2, all coronaviruses enter cells through this ACE2 protein and cause diseases. At present, there is no effective drug available in the world to prevent the virus from invading human cells, and pharmaceutical companies in my country and many developed countries are stepping up research and development. The vaccine is still in the process of research and development. Although the success of the vaccine research and development is relatively ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/07A61K38/08A61K38/10A61K38/16A61P31/14A23L33/18
CPCA23V2002/00A61K38/07A61K38/08A61K38/10A61K38/168A23L33/18A61P31/14A23V2200/30A23V2250/55
Inventor 陈正望尧晨光
Owner HUAZHONG UNIV OF SCI & TECH